Boiko A, Vorobeychik G, Paty D, Devonshire V, Sadovnick D, University of British Columbia MS Clinic Neurologists (2002) Early onset multiple sclerosis: a longitudinal study. Neurology 59:1006–1010. https://doi.org/10.1212/wnl.59.7.1006 Article CAS PubMed Google Scholar McKay KA, Manouche...
Angela Curcio, MD Columbia Univeristy Department of Neurology, New York, NY, USA Louis Dang, MD, PhD University of Michigan Health System, Ann Arbor, MI, USA Danielle de Campo, MD Johns Hopkins Hospital, Baltimore, MD, USA Radhika Dhamija, MBBS Mayo Clinic, Phoenix, AZ, USA Wendy Edlund...
Columbia University Medical Center UC San Diego CERN Medical Research University of Wolver Hampton University of Chicago University Hospital Heidelberg University of Michigan Health System Duke University in Durham, NC Washington University in St. Louis, MO University of California Harvard Medical School UC...
Corresponding Author: Iryna Lobanova, MD, Zeenat Qureshi Stroke Institute, Department of Neurology, University of Missouri, One Hospital Drive, CE507, Columbia, MO 65212 (lobanovanmu@gmail.com). Published Online: September 8, 2020. doi:10.1001/jamaneurol.2020.3075 Correction: This article was corre...
and Mary Kilty, MBA, MPH (Columbia University Coordinating Center, New York, New York); Daragh Heitzman, MD, FAAN, Wendy Rodriguez, NRCMA, Shari Hand, BS, CCRC, Michelle Washington, NRCMA, Brent Spears, BS, CCRC, and Brandie Burson, NRCMA (Texas Neurology, PA, Dallas); Richard S....
Neurofilament Light (NfL) is a biomarker for early neurodegeneration in Alzheimer’s disease (AD). This study aims to examine the association between plasma NfL and multi-modal neuroimaging features across the AD spectrum and whether NfL predicts future
The IFNB Multiple Sclerosis Study Group (1995) Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Neurology 45:1277–1285 ...
Multiple sclerosis (MS) is the most common cause of neurological disability in young adults worldwide and approximately half of those affected are in Europe. The assessment of differential incidence and prevalence across populations can reveal spatial, t
IFNB Multiple Sclerosis Study Group,University of British Columbia MS/MRI Analysis Group, Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995;451277- 1285PubMedGoogle ScholarCrossref 35. PRISMS Study Group,University of British...
(Poppas); Columbia University Irving Medical Center, New York, New York (Reddy); West Virginia University School of Medicine, Morgantown (Reece); Department of Medicine, The University of Texas Health Science Center at San Antonio (Reeves); Banner Alzheimer’s Institute, Phoenix, Arizona (Reiman...